Aptalis Pharma develops and markets therapies for the treatment of gastrointestinal diseases and disorders. read more
Brenton Saunders Aptalis Pharma CEO Rating
Brenton Saunders Aptalis Pharma CEO Rating
Aptalis Pharma's CEO, Brenton Saunders, has 4 employee ratings and a score of 83/100, placing them in the Top 5% of similar size companies on Comparably with 501-1,000 Employees and Top 5% of other companies in New York.
Where This Score Ranks Aptalis Pharma's CEO Rating
- TOP5%
In the Top 5% of 1832 Similar Sized Companies on Comparably
- TOP5%
In the Top 5% of 707 Nearby Companies in New York
- 2nd
2nd place versus 2 competitors rated on Comparably
80
Apr
75
Jan
A+83 / 100
Jan
Aptalis Pharma CEO Brenton Saunders Bio
Brenton Saunders serves as the CEO / President of Aptalis Pharma.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at Aptalis PharmaNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at Aptalis PharmaAptalis Pharma CEO Brenton Saunders At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Aptalis Pharma.
Based on 4 ratings, Brenton Saunders ranks right below Intercept Pharmaceuticals' CEO, Mark Pruzanski.
Overall, the CEO score has remained stable over the last 90 days.
Aptalis Pharma CEO Brenton Saunders Rating Trendline
- Aptalis Pharma
- Other Companies in New York66
- Similar Size on Comparably64
Aptalis Pharma's CEO Rating Rank Against Similar Sized Companies on Comparably
TOP
5%
Aptalis Pharma ranks in the Top 5% of other companies on Comparably with 501-1,000 Employees for CEO Rating Score.
Aptalis Pharma's CEO Rating Rank Against Other Companies Nearby
TOP
5%
Aptalis Pharma ranks in the Top 5% of other companies in New York for CEO Rating Score.
Anonymously Ask Aptalis Pharma Any Question
Are You an Employee at Aptalis Pharma?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Aptalis Pharma
×